Comprehensive Evaluation of Serum tRF-17-WS7K092 as a Promising Biomarker for the Diagnosis of Gastric Cancer

Figure 3

Evaluation of the diagnostic efficacy of serum tRF-17-WS7K092 in GC. (a) ROC analysis of tRF-17-WS7K092, CEA, CA199, and CA724 in the independent diagnosis of GC patients and healthy donors. (b, c) ROC analysis of tRF-17-WS7K092, CEA, CA199, and CA724 in the joint diagnosis of GC patients and healthy donors. (d) ROC analysis of tRF-17-WS7K092, CEA, CA199, and CA724 in the independent diagnosis of GC patients and gastritis patients. (e, f) ROC analysis of tRF-17-WS7K092, CEA, CA199, and CA724 in the joint diagnosis of GC patients and gastritis patients.

(a)

(b)

(c)

(d)

(e)

(f)